EE348 The Cost-Effectiveness of Belimumab for the Treatment of Patients With Systemic Lupus Erythematosus (SLE) in China

Abstract

Authors

X He E Lloyd Y Asukai D Chauhan Z Tang M Treur

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×